Drug intelligence / Profile preview

Aquatabs

Development stage
Unknown
Lead developer
Medentech
Modality
Small Molecules
Administration
Oral
01

Overview

Aquatabs is a point-of-use water purification product containing sodium dichloroisocyanurate (NaDCC) as the active ingredient. Manufactured by Medentech, these effervescent tablets are designed to disinfect household drinking water by releasing a precise dose of free chlorine (hypochlorous acid). This process effectively reduces microbial contamination, including enteric pathogens such as *E. coli*, which are primary causes of diarrheal diseases. The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) has evaluated Aquatabs in large-scale randomized trials to assess their impact on reducing diarrhea prevalence among children in rural settings where tubewell water is a primary source. The tablets provide a stable and portable method for water treatment, ensuring safety during storage and transport by providing residual protection against recontamination.

Brand names
Aquatabs
Other names
Sodium dichloroisocyanurateNaDCCAquatab
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Aquatabs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquatabs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call